Atom Therapeutics Overview
- Year Founded
-
2012
- Status
-
IPO Registration
- Employees
-
60
- Latest Deal Type
-
IPO
- (Announced)
- Financing Rounds
-
12
Atom Therapeutics General Information
Description
Developer of small-molecule drugs designed for metabolic, inflammatory, and cardiovascular diseases. The company utilizes urat1 inhibition and nlrp3 inflammasome inhibition to target inflammatory cascades, providing the healthcare industry with chronic gout therapeutics, acute gout anti-inflammatories, hyperuricemia treatments, atherosclerotic cardiovascular disease drugs, chronic kidney disease medications, and anti-cancer agents to treat chronic and acute conditions.
Contact Information
Website
www.atomthera.usCorporate Office
- Suite 306, Building 21, Hexiang Technology Center, Xiasha Street
- Qiantang District
- Hangzhou, Zhejiang 310018
- China
Corporate Office
- Suite 306, Building 21, Hexiang Technology Center, Xiasha Street
- Qiantang District
- Hangzhou, Zhejiang 310018
- China
Atom Therapeutics Timeline
Atom Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Atom Therapeutics Comparisons
Industry
Financing
Details
Atom Therapeutics Competitors (2)
One of Atom Therapeutics’s 2 competitors is AnHeart Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnHeart Therapeutics | Formerly VC-backed | New York, NY | ||||
| NeoX Biotech | Venture Capital-Backed | Beijing, China |
Atom Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atom Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Atom Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Atom Therapeutics FAQs
-
When was Atom Therapeutics founded?
Atom Therapeutics was founded in 2012.
-
Where is Atom Therapeutics headquartered?
Atom Therapeutics is headquartered in Hangzhou, China.
-
What is the size of Atom Therapeutics?
Atom Therapeutics has 60 total employees.
-
What industry is Atom Therapeutics in?
Atom Therapeutics’s primary industry is Drug Discovery.
-
Is Atom Therapeutics a private or public company?
Atom Therapeutics is a Private company.
-
What is Atom Therapeutics’s current revenue?
The current revenue for Atom Therapeutics is .
-
How much funding has Atom Therapeutics raised over time?
Atom Therapeutics has raised $70M.
-
Who are Atom Therapeutics’s investors?
ENN Energy Holdings, Heda Ventures, Huajin Investment, Huajin Venture Capital, and Xinyi Asset Management are 5 of 17 investors who have invested in Atom Therapeutics.
-
Who are Atom Therapeutics’s competitors?
AnHeart Therapeutics and NeoX Biotech are competitors of Atom Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
